Applied DNA Sciences (APDN) Tops Q3 EPS by 417c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts APDN Hot Sheet
Price: $5.62 --0%
Financial Fact:
NET LOSS FROM OPERATIONS: -2.41M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
NET LOSS FROM OPERATIONS: -2.41M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of $0.47, $4.17 better than the analyst estimate of ($3.70). Revenue for the quarter came in at $800 thousand versus the consensus estimate of $1.18 million.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- HCI Group (HCI) Tops Q3 EPS by 245c
- National Fuel Gas (NFG) Tops Q4 EPS by 18c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
